

Health Care: Drugs
SeraCare Life Sciences Inc. (SRLS: NASDAQ)
$4.01 0.00 | 0.00%
04/20/12 - 04:00 PM ET
41.39K / 228.10K
Vol / Avg. Vol:
4.00 / 4.01
Open / Prev. Close:
3.99 - 4.01
Today's Range:
Portfolios with SRLS
Latest SRLS Headlines from TheStreet
More Financial News for SRLS
Press Releases for SRLS
- SeraCare Shareholders Approve Acquisition By Linden Capital Partners - PR Newswire 04.18.12 | 11:04 am
- Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Seracare Life Sciences, Inc. - Business Wire 02.29.12 | 05:02 pm
- Goldfarb LLP Securities Lawyers Seek More Money, Information For Shareholders In SeraCare Life Sciences Buyout - PR Newswire 02.23.12 | 10:02 am
- Bull & Lifshitz, LLP Announces Investigation Of SeraCare Life Sciences, Inc. - PR Newswire 02.18.12 | 09:02 am
- The Law Firm Of Weiss & Lurie Investigates SeraCare Life Sciences, Inc. - Business Wire 02.15.12 | 05:02 pm
- Law Office Of Brodsky & Smith, LLC Announces Investigation Of SeraCare Life Sciences, Inc. - Business Wire 02.15.12 | 12:02 pm
- Holzer Holzer & Fistel, LLC Announces Investigation Into The Proposed Buyout Of SeraCare Life Sciences - Business Wire 02.14.12 | 11:02 am
- SeraCare Life Sciences Alert: The Briscoe Law Firm And Powers Taylor, LLP Investigate The Board Of SeraCare Life Sciences, Inc. Concerning The Sale Of SRLS To Linden Capital Partners - PR Newswire 02.14.12 | 11:02 am
- Ryan & Maniskas, LLP Announces Investigation Of SeraCare Life Sciences Inc. - Business Wire 02.14.12 | 11:02 am
- Law Office Of Brodsky & Smith, LLC Announces Investigation Of SeraCare Life Sciences, Inc. - PR Newswire 02.13.12 | 04:02 pm
See All Press Releases
Partner Headlines for SRLS